New family of protein-based antagonists shows promise against leukemia
In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, University Hospital Tübingen, and Osnabrück University successfully designed a new family of protein-based ...
18 hours ago
0
0
Regular physical activity before cancer diagnosis may lower progression and death risks
Regular physical activity before a cancer diagnosis may lower the risks of both disease progression and death, suggests research published online in the British Journal of Sports Medicine.
15 hours ago
0
1
Q&A: How early cancer screening could save Canada nearly half a billion dollars over patients' lifetimes
Cancer screening is key to saving patients' lives, since an earlier stage diagnosis improves survival rates, decreases morbidity, and leads to less intensive treatments. Early detection also has the potential to save Canada's ...
17 hours ago
0
0
Can you steam away prostate cancer? Clinical trial offers steam to potentially destroy cancer cells in patients
Steam eliminates wrinkles and germs, but can it destroy cancer cells too?
20 hours ago
0
3
Approved drug dronedarone found to inhibit the proliferation of esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and contributing significantly to cancer-related mortality globally. Despite advancements in combination ...
16 hours ago
0
0
Global study reveals younger adults face rising gastric cancer risk
A global study reveals a disturbing rise in early-onset gastric cancer, a disease once predominantly affecting older adults but now increasingly impacting younger populations. This shift in disease patterns, uncovered through ...
16 hours ago
0
0
New AI tool uses routine blood tests to predict immunotherapy response for many cancers
Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors—a type of immunotherapy—using only routine blood ...
Jan 7, 2025
0
53
Childhood cancer genome study reveals hidden variants
Researchers at Dana-Farber Cancer Institute collaborated with multiple institutions to pinpoint rare germline structural variants as risk factors for non-blood-related cancers in children, including tumors in various organs. ...
Biolasers light up circulating tumor cells in the bloodstream
Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients.
Jan 6, 2025
0
14
Novel screening tech enhances identification of cancer-targeting T cell receptors
Researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have developed a new screening technology, Aptamer-based T Lymphocyte Activity Screening and ...
Jan 6, 2025
0
27
Discovery of immune-boosting fibroblasts offers hope for cancer patients
Southampton scientists working to improve survival for cancer patients have identified a key characteristic of the disease that could make treatment more effective.
Jan 6, 2025
0
0
Localized magnetic fields boost chemotherapy uptake in breast cancer treatment, researchers find
Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiveness of chemotherapy while reducing its harmful side effects.
Jan 6, 2025
0
1
Would cancer warning labels on alcoholic beverages reduce consumption—or be ignored?
Calling alcohol the third-leading preventable cause of cancer, the U.S. surgeon general on Friday recommended that alcoholic beverages come with the same type of warning label currently used on packs of cigarettes.
Jan 6, 2025
0
0
Decrease seen in in situ breast cancer since 2009
The incidence of in situ breast cancer has decreased since 2009, consistent with decreasing use of mammography in association with the 2009 U.S. Preventive Services Task Force (USPSTF) guideline change, according to a study ...
Jan 6, 2025
0
0
ING5 inhibits aerobic glycolysis of lung cancer cells: Study
Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis being the primary contributor to poor patient outcomes. A critical factor in this devastating disease ...
Jan 6, 2025
0
0
The elimination of cervical cancer in NZ is within reach—but not without funding and a plan
After committing to a global plan to eliminate cervical cancer, New Zealand is lagging behind Australia and other countries in how it manages this preventable disease.
Jan 5, 2025
0
0
Tonsil cancer: What is it and how to prevent it
Tonsil cancer is a type of head and neck cancer. Head and neck cancers include cancers of the tongue; the back of the tongue, which you can't see when you look in the mirror; the tonsils; or the throat, which includes several ...
Jan 4, 2025
0
0
Scientists unveil surprising human vs. mouse differences in a major cancer immunotherapy target
Since its discovery in the 1990s, programmed cell death protein 1 (PD-1) has been regarded as a leading target in cancer treatments. A checkpoint receptor that often resides on the surface of immune system cells, the PD-1 ...
Jan 3, 2025
0
63
Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases
A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.
Jan 3, 2025
0
41
Mini-tumors from circulating breast cancer cells offer new treatment insights
Tumor cells circulating in the blood are the germ cells of breast cancer metastases. They are very rare and have not been propagated in the culture dish until now, which made research into therapy resistance difficult.
Jan 3, 2025
0
105
Surprising 'two-faced' cancer gene role supports paradigm shift in predicting disease
A genetic fault long believed to drive the development of esophageal cancer may in fact play a protective role early in the disease, according to new research published in Nature Cancer. This unexpected discovery could help ...
Jan 3, 2025
0
34
FDA approves subcutaneous opdivo qvantig for most solid tumor indications
The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for subcutaneous use for most previously approved adult, solid tumor Opdivo (nivolumab) indications.
Jan 3, 2025
0
0
Improving predictions about brain cancer outcomes with the right imaging criteria
A paper published in the Journal of Clinical Oncology, titled "Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in ...
Jan 3, 2025
0
0